Alts Watch Healthcare Beat: Nearly $1bn in fresh capital flows in latest life sciences deals

In numerical terms, our latest recon of private market investment in the life sciences is about on par with the previous week: 13 deals with a total value of $987 million.

But there was a noticeable difference on the focus of the deals. Drugmakers (mostly in the biotechnology space) took the lion's share of funding in our previous tallies, but this time much of the funding accrues to digital health . . .

Continue Reading With Our Special Offer

Unlock this article instantly, along with the rest of our premium content and newsletters, with a 20% discount by using the coupon code VIDRIO2021.

Get this deal

Already a subscriber? Log in.

Sergio Barreto

Sergio Barreto is about 70% journalist, 30% tech geek. As an editor for The ABIS Group, he produces daily newsletters for leading healthcare and technology companies. With BMV Digital, he provides WordPress-based web developments services. Here at Alternatives Watch, he wears both hats - handling IT and occasionally writing about the intersection of alts, healthcare and tech.

Related Articles

Back to top button

Get our daily news digest
in your inbox

Our FREE mailing list brings you daily alts intel.

Thank you for subscribing.

Something went wrong.